Mitsubishi Tanabe Pharma America, Inc. (MTPA) is relentlessly focused on the goal of providing therapies for some of the most difficult-to-treat diseases, including amyotrophic lateral sclerosis (ALS). Our teams work diligently to develop smart options that will enable healthcare providers to offer safe and effective treatments for devastating illnesses. We thrive on solving complex problems in science and medicine and strive to make a real difference in the lives of people struggling with debilitating diseases.
As part of our mission, we work closely with advocacy organizations focused on addressing the needs of the ALS community. We are grateful for the opportunity to participate in the ALS Association NYC Walk to Defeat ALS and raise awareness of the patients and caregivers facing this disease.